Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-05-01

FDA Approved: AMITRIPTYLINE HYDROCHLORIDE — Original Application (Advagen Pharma Ltd)

View source ↗

Summary

FDA approved Advagen Pharma Ltd's original application for Amitriptyline Hydrochloride (generic) under ANDA, authorizing its marketing in the United States.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amitriptyline hydrochloride (amitriptyline hydrochloride)

Snippet

ORIG AP for AMITRIPTYLINE HYDROCHLORIDE (AMITRIPTYLINE HYDROCHLORIDE)